Asia-Pacific Journal of Oncology Nursing

EDITORIAL
Year
: 2021  |  Volume : 8  |  Issue : 4  |  Page : 349--351

Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab


Liyi Zhang 
 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Correspondence Address:
PhD, MD Liyi Zhang
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou
China




How to cite this article:
Zhang L. Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab.Asia Pac J Oncol Nurs 2021;8:349-351


How to cite this URL:
Zhang L. Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab. Asia Pac J Oncol Nurs [serial online] 2021 [cited 2021 Jun 20 ];8:349-351
Available from: https://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=4;spage=349;epage=351;aulast=Zhang;type=0